Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
27
# OF OVERLAPPING
HOLDINGS
VHT
403
HOLDINGS
7%
ALSO IN GDOC
GDOC
39
HOLDINGS
73%
ALSO IN VHT
SECTOR DRIFT (VHT minus GDOC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in GDOC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.0% | 8.1% | 8.1% |
|
ABBVIE INC | 5.4% | 6.3% | 5.4% |
|
MERCK & CO. INC. | 3.7% | 3.6% | 3.6% |
|
ABBOTT LABORATORIES | 3.4% | 5.1% | 3.4% |
|
UNITEDHEALTH GROUP INC | 4.2% | 3.3% | 3.3% |
VHT Overweight Relative to GDOC
|
ELI LILLY & CO | 4.9% |
|
JOHNSON & JOHNSON | 4.6% |
|
THERMO FISHER SCIENTIFIC INC | 3.4% |
|
AMGEN INC | 2.8% |
|
GILEAD SCIENCES INC | 2.4% |
|
PFIZER INC | 2.2% |
 |
MEDTRONIC PLC | 2.0% |
|
STRYKER CORP | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.7% |
|
MCKESSON CORP | 1.7% |
VHT Underweight Relative to GDOC
|
BOSTON SCIENTIFIC CORP | -6.8% |
|
INSULET CORP | -5.8% |
 |
ASTRAZENECA PLC | -4.4% |
 |
LONZA GROUP AG-REG | -3.2% |
 |
HOYA CORP | -3.0% |
 |
ARGENX SE ADR | -3.0% |
|
COOPER COS INC/THE | -2.8% |
 |
CSL LIMITED | -2.6% |
|
BIOMARIN PHARMACEUTICAL INC | -2.5% |
|
NEUROCRINE BIOSCIENCES INC | -2.5% |